Zhuang Ping, Wo Da, Xu Zeng-Guang, Wei Wei, Mao Hui-ming
Shanghai International Medical Center, Shanghai, People's Republic of China.
Department of Central Laboratory, Shanghai East Hospital, Tongji University, 150 Jimo Road, Pudong New District, Shanghai 200120, People's Republic of China.
J Clin Neurosci. 2015 Jul;22(7):1123-7. doi: 10.1016/j.jocn.2014.12.027. Epub 2015 May 19.
The aim of this paper is to investigate the corresponding variations of plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) activities, and beta-thromboglobulin (β-TG) content in patients during different stages of ischemic stroke. Ischemic stroke is a common disease among aging people and its occurrence is associated with abnormalities in the fibrinolytic system and platelet function. However, few reports focus on the dynamic changes in the plasma fibrinolytic system and β-TG content in patients with ischemic stroke. Patients were divided into three groups: acute, convalescent and chronic. Plasma t-PA and PAI-1 activities were determined by chromogenic substrate analysis and plasma β-TG content was detected by radioimmunoassay. Patients in the acute stage of ischemic stroke had significantly increased levels of t-PA activity and β-TG content, but PAI-1 activity was significantly decreased. Negative correlations were found between plasma t-PA and PAI-1 activities and between plasma t-PA activity and β-TG content in patients with acute ischemic stroke. There were significant differences in plasma t-PA and PAI-1 activities in the aged control group, as well as in the acute, convalescent and chronic groups. It can be speculated that the increased activity of t-PA in patients during the acute stage was the result of compensatory function, and that the increase in plasma β-TG level not only implies the presence of ischemic stroke but is likely a cause of ischemic stroke. During the later stages of ischemic stroke, greater attention is required in monitoring levels of PAI-1.
本文旨在研究缺血性中风不同阶段患者血浆组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂-1(PAI-1)活性以及β-血小板球蛋白(β-TG)含量的相应变化。缺血性中风是老年人中的常见疾病,其发生与纤溶系统和血小板功能异常有关。然而,很少有报道关注缺血性中风患者血浆纤溶系统和β-TG含量的动态变化。患者被分为三组:急性期、恢复期和慢性期。采用发色底物分析法测定血浆t-PA和PAI-1活性,采用放射免疫分析法检测血浆β-TG含量。缺血性中风急性期患者的t-PA活性和β-TG含量显著升高,但PAI-1活性显著降低。急性缺血性中风患者血浆t-PA与PAI-1活性之间以及血浆t-PA活性与β-TG含量之间呈负相关。老年对照组以及急性期、恢复期和慢性期患者的血浆t-PA和PAI-1活性存在显著差异。可以推测,急性期患者t-PA活性增加是代偿功能的结果,血浆β-TG水平升高不仅意味着存在缺血性中风,而且可能是缺血性中风的一个原因。在缺血性中风后期,需要更加关注PAI-1水平的监测。